These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
551 related articles for article (PubMed ID: 16797483)
1. Panic and avoidance in panic disorder with agoraphobia: clinical relevance of change in different aspects of the disorder. Ramnerö J; Ost LG J Behav Ther Exp Psychiatry; 2007 Mar; 38(1):29-39. PubMed ID: 16797483 [TBL] [Abstract][Full Text] [Related]
2. Cognitive factors in panic disorder, agoraphobic avoidance and agoraphobia. Berle D; Starcevic V; Hannan A; Milicevic D; Lamplugh C; Fenech P Behav Res Ther; 2008 Feb; 46(2):282-91. PubMed ID: 18191103 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of change in cognitive therapy for panic disorder with agoraphobia. Hoffart A; Sexton H; Hedley LM; Martinsen EW J Behav Ther Exp Psychiatry; 2008 Sep; 39(3):262-75. PubMed ID: 17727812 [TBL] [Abstract][Full Text] [Related]
4. The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial. Bandelow B; Broocks A; Pekrun G; George A; Meyer T; Pralle L; Bartmann U; Hillmer-Vogel U; Rüther E Pharmacopsychiatry; 2000 Sep; 33(5):174-81. PubMed ID: 11071019 [TBL] [Abstract][Full Text] [Related]
5. Heightened embarrassability discriminates between panic disorder patients with and without agoraphobia. Swoboda H; Demal U; Krautgartner M; Amering M J Behav Ther Exp Psychiatry; 2003; 34(3-4):195-204. PubMed ID: 14972667 [TBL] [Abstract][Full Text] [Related]
6. Prediction of outcome in the behavioural treatment of panic disorder with agoraphobia. Ramnerö J; Ost LG Cogn Behav Ther; 2004; 33(4):176-80. PubMed ID: 15625791 [TBL] [Abstract][Full Text] [Related]
7. Assessing the clinical utility of agoraphobia in the context of panic disorder. Schmidt NB; Cromer KR Depress Anxiety; 2008; 25(2):158-66. PubMed ID: 17351905 [TBL] [Abstract][Full Text] [Related]
8. Quality of life and treatment outcome in panic disorder: cognitive behavior group therapy effects in patients refractory to medication treatment. Heldt E; Blaya C; Isolan L; Kipper L; Teruchkin B; Otto MW; Fleck M; Manfro GG Psychother Psychosom; 2006; 75(3):183-6. PubMed ID: 16636634 [TBL] [Abstract][Full Text] [Related]
9. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. Gloster AT; Wittchen HU; Einsle F; Lang T; Helbig-Lang S; Fydrich T; Fehm L; Hamm AO; Richter J; Alpers GW; Gerlach AL; Ströhle A; Kircher T; Deckert J; Zwanzger P; Höfler M; Arolt V J Consult Clin Psychol; 2011 Jun; 79(3):406-20. PubMed ID: 21534651 [TBL] [Abstract][Full Text] [Related]
10. Cognitive behavior therapy vs exposure in vivo in the treatment of panic disorder with agoraphobia (corrected from agrophobia). Ost LG; Thulin U; Ramnerö J Behav Res Ther; 2004 Oct; 42(10):1105-27. PubMed ID: 15350853 [TBL] [Abstract][Full Text] [Related]
11. Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial. Emmrich A; Beesdo-Baum K; Gloster AT; Knappe S; Höfler M; Arolt V; Deckert J; Gerlach AL; Hamm A; Kircher T; Lang T; Richter J; Ströhle A; Zwanzger P; Wittchen HU Psychother Psychosom; 2012; 81(3):161-72. PubMed ID: 22399019 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of panic disorders and agoraphobia. Psychotherapy, psychopharmacotherapy and their combination]. Frommberger U; Angenendt J; Berger M Nervenarzt; 1995 Mar; 66(3):173-86. PubMed ID: 7753242 [TBL] [Abstract][Full Text] [Related]
13. Avoidance behavior in panic disorder: the moderating influence of perceived control. White KS; Brown TA; Somers TJ; Barlow DH Behav Res Ther; 2006 Jan; 44(1):147-57. PubMed ID: 16300725 [TBL] [Abstract][Full Text] [Related]
14. [Panic disorder and panic attack]. Abbar M Encephale; 1996 Dec; 22 Spec No 5():13-8. PubMed ID: 9138941 [TBL] [Abstract][Full Text] [Related]
15. Anxiety sensitivity: a missing piece to the agoraphobia-without-panic puzzle. Hayward C; Wilson KA Behav Modif; 2007 Mar; 31(2):162-73. PubMed ID: 17307933 [TBL] [Abstract][Full Text] [Related]
16. [Group psychotherapy in patients with panic disorder and agoraphobia]. Scheibe G; Albus M; Walther AU; Schmauss M Psychother Psychosom Med Psychol; 1993 Jul; 43(7):238-44. PubMed ID: 8337352 [TBL] [Abstract][Full Text] [Related]
17. Quality of life in early phases of panic disorder: predictive factors. Carrera M; Herrán A; Ayuso-Mateos JL; Sierra-Biddle D; Ramírez ML; Ayestarán A; Hoyuela F; Rodríguez-Cabo B; Vázquez-Barquero JL J Affect Disord; 2006 Aug; 94(1-3):127-34. PubMed ID: 16762421 [TBL] [Abstract][Full Text] [Related]
18. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619 [TBL] [Abstract][Full Text] [Related]
19. The structure of lifetime panic-agoraphobic spectrum. Rucci P; Miniati M; Oppo A; Mula M; Calugi S; Frank E; Shear MK; Mauri M; Pini S; Cassano GB J Psychiatr Res; 2009 Jan; 43(4):366-79. PubMed ID: 18499126 [TBL] [Abstract][Full Text] [Related]